Recombinant plasminogen agent continues to show promise in trials.
D004274:DNA, Recombinant; D004341:Drug Evaluation; D006801:Humans; D007263:Infusions, Parenteral; D009203:Myocardial Infarction / Q000188:drug therapy*; D010960:Plasminogen Activators / Q000627:therapeutic use*
D004274:DNA, Recombinant; D010960:Plasminogen Activators